Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDApplied Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.22 | -$0.16 | -$0.18 |
| Q2 2025 | 2 | -$0.17 | -$0.16 | -$0.17 |
| Q3 2025 | 2 | -$0.14 | -$0.13 | -$0.14 |
| Q4 2025 | 2 | -$0.13 | -$0.09 | -$0.12 |
| Q1 2026 | 2 | -$0.11 | -$0.08 | -$0.10 |
| Q2 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
Applied Therapeutics, Inc. Earnings Date And Information
Applied Therapeutics, Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.13046 earnings per share for the quarter, topping analysts' consensus estimates of $-0.14097 by $0.01051. The company had revenue of 1.00 M for the quarter and had revenue of 455.00 K for the year. Applied Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.76 diluted earnings per share) and currently has a price-to-earnings ratio of -1.77. Applied Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 13th, 2025 based on prior year's report dates.
Applied Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$0.14 | -$0.13 | 0.01 | $333.33 K | $1.00 M |
| 08/13/2025 | Q2 2025 | -$0.17 | -$0.15 | 0.02 | $416.67 K | $0 |
| 05/13/2025 | Q1 2025 | N/A | -$0.15 | N/A | N/A | $0 |
| 04/14/2025 | Q4 2024 | N/A | $0.32 | N/A | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.16 | -$0.48 | -0.32 | $75.00 K | $122.00 K |
| 08/07/2024 | Q2 2024 | -$0.16 | $0.02 | 0.18 | $2.50 M | $144.00 K |
| 05/09/2024 | Q1 2024 | -$0.16 | -$0.67 | -0.51 | N/A | $190.00 K |
| 03/06/2024 | Q4 2023 | -$0.19 | -$0.45 | -0.26 | N/A | $-667,000 |
| 11/09/2023 | Q3 2023 | -$0.24 | -$0.47 | -0.23 | $8.00 M | $0 |
| 08/10/2023 | Q2 2023 | -$0.27 | -$0.37 | -0.1 | $20.00 M | $0 |
| 05/11/2023 | Q1 2023 | -$0.31 | -$0.18 | 0.13 | N/A | $10.66 M |
| 03/23/2023 | Q4 2022 | -$0.46 | -$0.12 | 0.34 | N/A | $0 |
| 11/09/2022 | Q3 2022 | -$0.48 | -$0.40 | 0.08 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.75 | -$1.28 | -0.53 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.83 | -$0.88 | -0.05 | N/A | $0 |
| 03/10/2022 | Q4 2021 | -$1.20 | -$1.05 | 0.15 | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$1.09 | N/A | N/A | $0 |
| 08/12/2021 | Q2 2021 | N/A | -$0.99 | N/A | N/A | $0 |
| 05/11/2021 | Q1 2021 | N/A | -$1.00 | N/A | N/A | $0 |
| 03/18/2021 | Q4 2020 | N/A | -$0.98 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Applied Therapeutics, Inc. Earnings: FAQ's
Applied Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 13th, 2025 based offlast year's report dates.
In the previous quarter, Applied Therapeutics, Inc. (:APLT) reported $-0.13046 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.14097 by $0.01051.
The conference call for Applied Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Applied Therapeutics, Inc.'s latest earnings report can be read online.
Applied Therapeutics, Inc. (:APLT) has a recorded annual revenue of $455.00 K.
Applied Therapeutics, Inc. (:APLT) has a recorded net income of $-105,624,000.Applied Therapeutics, Inc. has generated $-0.76 earnings per share over the last four quarters.
Applied Therapeutics, Inc. (:APLT) has a price-to-earnings ratio of -1.77 and price/earnings-to-growth ratio is -0.02.